Innocoll Pharms Drug Patent Portfolio
Innocoll Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Innocoll Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11746141 | Modified collagen | 09 Jan, 2033 | Active |
| USRE47826 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage | 20 May, 2029 | Active |
Latest Legal Activities on Innocoll Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Innocoll Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 05 Sep, 2023 | US11746141 |
| Recordation of Patent eGrant | 05 Sep, 2023 | US11746141 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Sep, 2023 | US11746141 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Sep, 2023 | US11746141 |
| Mail Patent eGrant Notification | 05 Sep, 2023 | US11746141 |
| Patent eGrant Notification | 05 Sep, 2023 | US11746141 |
|
Email Notification
Critical
| 18 Aug, 2023 | US11746141 |
|
Issue Notification Mailed
Critical
| 16 Aug, 2023 | US11746141 |
|
Application Is Considered Ready for Issue
Critical
| 20 Jul, 2023 | US11746141 |
| Dispatch to FDC | 20 Jul, 2023 | US11746141 |
|
Issue Fee Payment Verified
Critical
| 17 Jul, 2023 | US11746141 |
|
Issue Fee Payment Received
Critical
| 17 Jul, 2023 | US11746141 |
| Miscellaneous Incoming Letter | 14 Jul, 2023 | US11746141 |
|
Electronic Review
Critical
| 25 May, 2023 | US11746141 |
|
Email Notification
Critical
| 25 May, 2023 | US11746141 |
Innocoll Pharms's Family Patents
Innocoll Pharms Drug List
Given below is the complete list of Innocoll Pharms's drugs and the patents protecting them.
1. Xaracoll
Xaracoll is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11746141 | Modified collagen |
09 Jan, 2033
(8 years from now)
| Active |
| USRE47826 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
20 May, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xaracoll's drug page